Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05817721Completed

PROTon Pump Inhibitors and Stent OCclusion Rate Of Lumen Apposing Metal Stents

Role: collaborator

NCT03356392Recruiting

German Stroke Registry - Endovascular Treatment

Role: collaborator

NCT03638700Not ApplicableCompleted

Comparison of Two High Performance Guidewires in ERCP

Role: collaborator

NCT03788655Unknown

Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract

Role: collaborator

NCT03763214Not ApplicableUnknown

PTFE Stents for Treatment of Malignant Biliary Strictures

Role: collaborator

NCT01836900Not ApplicableUnknown

Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard Therapy

Role: collaborator

All 6 trials loaded